These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 12559621)
1. Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands. Becker S; Tonn T; Füssel T; Uhrberg M; Bogdanow M; Seifried E; Seidl C Hum Immunol; 2003 Feb; 64(2):183-93. PubMed ID: 12559621 [TBL] [Abstract][Full Text] [Related]
3. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes. Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903 [TBL] [Abstract][Full Text] [Related]
4. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis]. Guo KY; Mei JZ; Yao KT Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963 [TBL] [Abstract][Full Text] [Related]
5. Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C. Vollmers S; Lobermeyer A; Niehrs A; Fittje P; Indenbirken D; Nakel J; Virdi S; Brias S; Trenkner T; Sauer G; Peine S; Behrens GMN; Lehmann C; Meurer A; Pauli R; Postel N; Roider J; Scholten S; Spinner CD; Stephan C; Wolf E; Wyen C; Richert L; Norman PJ; Sauter J; Schmidt AH; Hoelzemer A; Altfeld M; Körner C Front Immunol; 2022; 13():922252. PubMed ID: 35911762 [TBL] [Abstract][Full Text] [Related]
6. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. Karlsen TH; Boberg KM; Olsson M; Sun JY; Senitzer D; Bergquist A; Schrumpf E; Thorsby E; Lie BA J Hepatol; 2007 May; 46(5):899-906. PubMed ID: 17383044 [TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals. Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031 [TBL] [Abstract][Full Text] [Related]
8. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Shilling HG; McQueen KL; Cheng NW; Shizuru JA; Negrin RS; Parham P Blood; 2003 May; 101(9):3730-40. PubMed ID: 12511415 [TBL] [Abstract][Full Text] [Related]
9. Multifactorial determinants of NK cell repertoire organization: insights into age, sex, KIR genotype, HLA typing, and CMV influence. Ferron E; David G; Willem C; Legrand N; Salameh P; Anquetil L; Walencik A; Gendzekhadze K; Gagne K; Retière C Front Immunol; 2024; 15():1389358. PubMed ID: 38736873 [TBL] [Abstract][Full Text] [Related]
10. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer. Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais. Chaisri S; Kitcharoen K; Romphruk AV; Romphruk A; Witt CS; Leelayuwat C Immunogenetics; 2013 Sep; 65(9):645-53. PubMed ID: 23812166 [TBL] [Abstract][Full Text] [Related]
12. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors. Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859 [TBL] [Abstract][Full Text] [Related]
13. Diversity of killer cell immunoglobulin-like receptor genes in Pacific Islands populations. Velickovic M; Velickovic Z; Dunckley H Immunogenetics; 2006 Jul; 58(7):523-32. PubMed ID: 16733717 [TBL] [Abstract][Full Text] [Related]
14. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Uhrberg M; Parham P; Wernet P Immunogenetics; 2002 Jul; 54(4):221-9. PubMed ID: 12136333 [TBL] [Abstract][Full Text] [Related]
15. Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2 Nemat-Gorgani N; Hilton HG; Henn BM; Lin M; Gignoux CR; Myrick JW; Werely CJ; Granka JM; Möller M; Hoal EG; Yawata M; Yawata N; Boelen L; Asquith B; Parham P; Norman PJ J Immunol; 2018 Apr; 200(8):2640-2655. PubMed ID: 29549179 [TBL] [Abstract][Full Text] [Related]
16. HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma. Beelen NA; Molenbroeck SJJ; Groeneveld L; Voorter CE; Bos GMJ; Wieten L Immunogenetics; 2024 Jun; 76(3):155-164. PubMed ID: 38478091 [TBL] [Abstract][Full Text] [Related]
17. [KIRs on human NK cells and in relation with HLA class I antigen--review]. Dou LP; Da WM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):627-30. PubMed ID: 16800958 [TBL] [Abstract][Full Text] [Related]
18. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules. Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773 [TBL] [Abstract][Full Text] [Related]
19. Independent contributions of HLA epitopes and killer inhibitory receptor expression to the functional alloreactive specificity of natural killer cells. Young NT; Rust NA; Dallman MJ; Cerundolo V; Morris PJ; Welsh KI Hum Immunol; 1998 Nov; 59(11):700-12. PubMed ID: 9796738 [TBL] [Abstract][Full Text] [Related]
20. Distribution of killer cell immunoglobulin-like receptors in the Greek population. Niokou D; Spyropoulou-Vlachou M; Darlamitsou A; Stavropoulos-Giokas C Hum Immunol; 2003 Dec; 64(12):1167-76. PubMed ID: 14630399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]